Squarepoint’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $739K | Sell |
32,685
-24,664
| -43% | -$548K | ﹤0.01% | 3026 |
|
|
2025
Q4 | $1.48M | Buy |
57,349
+4,996
| +10% | +$119K | ﹤0.01% | 2280 |
|
|
2025
Q3 | $1.35M | Buy |
52,353
+30,946
| +145% | +$760K | ﹤0.01% | 2423 |
|
|
2025
Q2 | $512K | Buy |
+21,407
| New | +$540K | ﹤0.01% | 3257 |
|
|
2025
Q1 | – | Sell |
-60,836
| Closed | -$1.15M | – | 5274 |
|
|
2024
Q4 | $1.15M | Buy |
60,836
+25,505
| +72% | +$448K | ﹤0.01% | 2934 |
|
|
2024
Q3 | $532K | Buy |
35,331
+6,823
| +24% | +$117K | ﹤0.01% | 3045 |
|
|
2024
Q2 | $816K | Buy |
28,508
+6,794
| +31% | +$193K | ﹤0.01% | 2710 |
|
|
2024
Q1 | $634K | Buy |
+21,714
| New | +$667K | ﹤0.01% | 2882 |
|
|
2023
Q3 | – | Sell |
-20,715
| Closed | -$830K | – | 4151 |
|
|
2023
Q2 | $830K | Buy |
+20,715
| New | +$856K | ﹤0.01% | 2302 |
|
|
2023
Q1 | – | Sell |
-13,252
| Closed | -$512K | – | 3689 |
|
|
2022
Q4 | $512K | Buy |
13,252
+86
| +0.7% | +$4.18K | ﹤0.01% | 2274 |
|
|
2022
Q3 | $700K | Sell |
13,166
-1,377
| -9% | -$76.6K | 0.01% | 2004 |
|
|
2022
Q2 | $848K | Sell |
14,543
-26,663
| -65% | -$1.75M | 0.01% | 1706 |
|
|
2022
Q1 | $3.15M | Sell |
41,206
-4,886
| -11% | -$326K | 0.02% | 902 |
|
|
2021
Q4 | $2.77M | Sell |
46,092
-13,327
| -22% | -$735K | 0.01% | 1064 |
|
|
2021
Q3 | $3.33M | Buy |
59,419
+25,064
| +73% | +$1.44M | 0.02% | 963 |
|
|
2021
Q2 | $2.08M | Buy |
+34,355
| New | +$2.17M | 0.02% | 1161 |
|
|
2021
Q1 | – | Sell |
-15,336
| Closed | -$918K | – | 3509 |
|
|
2020
Q4 | $918K | Sell |
15,336
-10,985
| -42% | -$643K | 0.01% | 1400 |
|
|
2020
Q3 | $1.58M | Buy |
26,321
+16,906
| +180% | +$982K | 0.02% | 756 |
|
|
2020
Q2 | $494K | Buy |
+9,415
| New | +$393K | 0.01% | 1324 |
|
|
2020
Q1 | – | Sell |
-39,656
| Closed | -$1.8M | – | 2352 |
|
|
2019
Q4 | $1.8M | Buy |
39,656
+7,751
| +24% | +$329K | 0.01% | 969 |
|
|
2019
Q3 | $1.22M | Sell |
31,905
-2,835
| -8% | -$113K | 0.01% | 1093 |
|
|
2019
Q2 | $1.51M | Sell |
34,740
-81,810
| -70% | -$3.47M | 0.01% | 1006 |
|
|
2019
Q1 | $4.44M | Buy |
116,550
+81,822
| +236% | +$3.19M | 0.05% | 482 |
|
|
2018
Q4 | $1.49M | Buy |
34,728
+12,450
| +56% | +$581K | 0.02% | 777 |
|
|
2018
Q3 | $1.09M | Buy |
22,278
+11,289
| +103% | +$488K | 0.01% | 950 |
|
|
2018
Q2 | $352K | Buy |
+10,989
| New | +$379K | ﹤0.01% | 1322 |
|
|
2018
Q1 | – | Sell |
-10,680
| Closed | -$488K | – | 2024 |
|
|
2017
Q4 | $488K | Buy |
+10,680
| New | +$423K | 0.01% | 1226 |
|
|
2016
Q4 | – | Sell |
-28,592
| Closed | -$978K | – | 1887 |
|
|
2016
Q3 | $978K | Buy |
+28,592
| New | +$1.12M | 0.06% | 359 |
|
|
2015
Q4 | – | Sell |
-13,100
| Closed | -$538K | – | 1292 |
|
|
2015
Q3 | $538K | Buy |
+13,100
| New | +$802K | 0.13% | 187 |
|
Other funds holding PCRX
DPCM
VPM
VCM
